Literature DB >> 17311847

Requirement of subunit co-assembly and ankyrin-G for M-channel localization at the axon initial segment.

Hanne B Rasmussen1, Christian Frøkjaer-Jensen, Camilla S Jensen, Henrik S Jensen, Nanna K Jørgensen, Hiroaki Misonou, James S Trimmer, Søren-Peter Olesen, Nicole Schmitt.   

Abstract

The potassium channel subunits KCNQ2 and KCNQ3 are believed to underlie the M current of hippocampal neurons. The M-type potassium current plays a key role in the regulation of neuronal excitability; however, the subcellular location of the ion channels underlying this regulation has been controversial. We report here that KCNQ2 and KCNQ3 subunits are localized to the axon initial segment of pyramidal neurons of adult rat hippocampus and in cultured hippocampal neurons. We demonstrate that the localization of the KCNQ2/3 channel complex to the axon initial segment is favored by co-expression of the two channel subunits. Deletion of the ankyrin-G-binding motif in both the KCNQ2 and KCNQ3 C-terminals leads to the disappearance of the complex from the axon initial segment, albeit the channel complex remains functional and still reaches the plasma membrane. We further show that although heteromeric assembly of the channel complex favours localization to the axon initial segment, deletion of the ankyrin-G-binding motif in KCNQ2 alone does not alter the subcellular localization of KCNQ2/3 heteromers. By contrast, deletion of the ankyrin-G-binding motif in KCNQ3 significantly reduces AIS enrichment of the complex, implicating KCNQ3 as a major determinant of M channel localization to the AIS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17311847     DOI: 10.1242/jcs.03396

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  59 in total

1.  M-type potassium channels modulate Schaffer collateral-CA1 glutamatergic synaptic transmission.

Authors:  Jianli Sun; Jaideep Kapur
Journal:  J Physiol       Date:  2012-06-06       Impact factor: 5.182

Review 2.  The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life.

Authors:  Anthony J Baines
Journal:  Protoplasma       Date:  2010-07-29       Impact factor: 3.356

Review 3.  Membrane domains based on ankyrin and spectrin associated with cell-cell interactions.

Authors:  Vann Bennett; Jane Healy
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-08-19       Impact factor: 10.005

4.  The C-terminal domain of ßIV-spectrin is crucial for KCNQ2 aggregation and excitability at nodes of Ranvier.

Authors:  Jérôme J Devaux
Journal:  J Physiol       Date:  2010-10-20       Impact factor: 5.182

5.  Kv7.2 regulates the function of peripheral sensory neurons.

Authors:  Chih H King; Eric Lancaster; Daniela Salomon; Elior Peles; Steven S Scherer
Journal:  J Comp Neurol       Date:  2014-04-12       Impact factor: 3.215

6.  Inhibition of transmitter release from rat sympathetic neurons via presynaptic M(1) muscarinic acetylcholine receptors.

Authors:  H Kubista; K Kosenburger; P Mahlknecht; H Drobny; S Boehm
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

Review 7.  Localization and targeting of voltage-dependent ion channels in mammalian central neurons.

Authors:  Helene Vacher; Durga P Mohapatra; James S Trimmer
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

8.  Exon organization and novel alternative splicing of the human ANK2 gene: implications for cardiac function and human cardiac disease.

Authors:  Shane R Cunha; Solena Le Scouarnec; Jean-Jacques Schott; Peter J Mohler
Journal:  J Mol Cell Cardiol       Date:  2008-08-27       Impact factor: 5.000

Review 9.  Action potential initiation and propagation: upstream influences on neurotransmission.

Authors:  G J Kress; S Mennerick
Journal:  Neuroscience       Date:  2008-03-19       Impact factor: 3.590

Review 10.  Neural KCNQ (Kv7) channels.

Authors:  David A Brown; Gayle M Passmore
Journal:  Br J Pharmacol       Date:  2009-03-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.